HLA DR15 (DR2) Immunosuppressive Response Association in Myelodysplastic Syndrome (MDS)

Casandra

Casandra Test Code LC57324Version 1 (DRAFT)

Performing Lab

Lab LabcorpLab Test ID 167100CPT Code 81377

HLA DR15 (DR2) Immunosuppressive Response Association in Myelodysplastic Syndrome (MDS)

Also known as: DR15, Immunosuppressive Response, MDS, Myelodysplastic Syndrome

Clinical Use

Order Test

Use

Determine the presence of DR15 antigen.

Special Instructions

When submitting buccal swabs, it is essential to use a buccal swab kit provided by LabCorp. For obtaining the buccal swab kit or additional assistance in selecting the appropriate HLA test, please contact LabCorp's HLA customer service at the specified number. This ensures proper specimen collection and handling, which is crucial for accurate test results.

Limitations

Despite all the necessary precautions, there may be instances where the specimen is not suitable for testing, necessitating a recollection. The test has been developed and characterized by LabCorp, with performance metrics available, though it has not received FDA clearance or approval for diagnostic use. Variations in specimen collection and handling can significantly impact test accuracy and reliability.

Test Details